Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Rockefeller
Sloan Kettering
Tri-Institutional MD-PhD Program
Explore this Website
Home
About Us
Toggle About Us menu options
Welcome from Dr. Katharine Hsu
Welcome from Tri-I Students
Leadership and Staff
Our Institutions
Contact Us
Getting to the Tri-Institutional Campus
Equal Education & Employment
Admissions
Toggle Admissions menu options
Transfer Policy
Admissions FAQs
Financial Support
Finance FAQs
Curriculum and Community
Toggle Curriculum and Community menu options
Program at a Glance
MD-PhD Specific Courses and Seminars
Tri-I Faculty
Our Students
Belonging at Tri-I
MD-PhD Houses
Student Housing
Life in New York City
Program FAQ
Tri-I Outcomes
Toggle Tri-I Outcomes menu options
Fellowships and Awards
Student Publications
Thesis Defenses
Residency Matches
Academic Career Progression
Career Paths of Our Alumni
Summer Program
Toggle Summer Program menu options
Gateways Admissions
Gateways To The Laboratory Summer Program FAQ
News and Events
Toggle News and Events menu options
Events Calendar
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Admissions
Curriculum and Community
Tri-I Outcomes
Summer Program
News and Events
Home
Biblio
Found 8 results
Filters:
Keyword
is
Antineoplastic Combined Chemotherapy Protocols
[Clear All Filters]
2018
Mateos M-V, Dimopoulos MA, Cavo M, Suzuki K, Jakubowiak A, Knop S, Doyen C, Lucio P, Nagy Z, Kaplan P et al.
. 2018.
Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma.
.
N Engl J Med. 378(6):518-528.
2017
Xue Y, Martelotto L, Baslan T, Vides A, Solomon M, Mai TThi, Chaudhary N, Riely GJ, Li BT, Scott K et al.
. 2017.
An approach to suppress the evolution of resistance in BRAF-mutant cancer.
.
Nat Med. 23(8):929-937.
Perez K, Clancy TE, Mancias JD, Rosenthal MH, Wolpin BM
. 2017.
When, What, and Why of Perioperative Treatment of Potentially Curable Pancreatic Adenocarcinoma.
.
J Clin Oncol. 35(5):485-489.
2016
Liang LW, Perez AR, Cangemi NA, Zhou Q, Iasonos A, Abu-Rustum N, Alektiar KM, Makker V
. 2016.
An Assessment of Prognostic Factors, Adjuvant Treatment, and Outcomes of Stage IA Polyp-Limited Versus Endometrium-Limited Type II Endometrial Carcinoma.
.
Int J Gynecol Cancer. 26(3):497-504.
2015
Kim D-Y, Joo Y-D, Lim S-N, Kim S-D, Lee J-H, Lee J-H, Kim DHwan Denni, Kim K, Jung CWon, Kim I et al.
. 2015.
Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia.
.
Blood. 126(6):746-56.
2014
Heath JL, Weiss JM, Lavau CP, Wechsler DS
. 2014.
Effects of iron depletion on CALM-AF10 leukemias.
.
Exp Hematol. 42(12):1022-1030.e1.
Steinman J, Ariyan C, Rafferty B, Brady MS
. 2014.
Factors associated with response, survival, and limb salvage in patients undergoing isolated limb infusion.
.
J Surg Oncol. 109(5):405-9.
2005
Halaas JL, Moskowitz CH, Horwitz S, Portlock C, Noy A, Straus D, O'Connor OA, Yahalom J, Zelenetz AD
. 2005.
R-CHOP-14 in patients with diffuse large B-cell lymphoma: feasibility and preliminary efficacy.
.
Leuk Lymphoma. 46(4):541-7.